Walking speed and brain glucose uptake are uncoupled in patients with multiple sclerosis

Abstract

Motor impairments of the upper and lower extremities are common symptoms of multiple sclerosis (MS). While some peripheral effects like muscle weakness and loss of balance have been shown to influence these symptoms, central nervous system activity has not been fully elucidated. The purpose of this study was to determine if alterations in glucose uptake were associated with motor impairments in patients with multiple sclerosis. Eight patients with multiple sclerosis (four men) and eight sex matched healthy controls performed 15 min of treadmill walking at a self-selected pace, during which ≈322MBq of the positron emission tomography (PET) glucose analog [18F]-fluorodeoxyglucose (FDG) was injected. Immediately after the cessation of walking, participants underwent PET imaging. Patients with MS had lower FDG uptake in ≈40% of the brain compared to the healthy controls (pFWE-corr <0.001, qFDR-corr <0.001, ke =93851) and walked at a slower speed [MS, 1.1 (0.2), controls 1.4 (0.1), m/s, P =0.014].Within the area of lower FDG uptake 15 regions were identified. Of these 15 regions, 13were found to have strong to moderate correlations to walking speed within the healthy controls (r>–0.75, P <0.032). Within patients with MS only 3 of the 15 regions showed significant correlations: insula (r =–0.74, P =0.036), hippocampus (r =–0.72, P =0.045), and calcarine sulcus (r =–0.77, P =0.026).This data suggest that walking impairments in patients with MS may be due to network wide alterations in glucose metabolism. Understanding howbrain activity and metabolism are altered in patients with MS may allow for better measures of disability and disease status within this clinical population.